Casirivimab and Imdevimab: Cipla, Roche launch antibody cocktail priced at Rs 59,750 per patient
The drug will be marketed in India by Cipla and the second batch will be made available by mid-June. The drug will be available through leading hospitals and Covid treatment centres
Boosting farmers’ incomes: Shahi Litchi from Bihar exported to United Kingdom
May 25, 2021, 1:39 PM IST
India, Israel sign agreement to enhance cooperation in agriculture
May 25, 2021, 12:34 PM IST
Covid-19: Engineering student delivers newspapers in mornings, carries forward father’s legacy
May 24, 2021, 7:24 PM IST
Covid-19: Dr Reddy’s Laboratories is targeting to launch new treatment alternatives
May 24, 2021, 6:46 PM IST
May 24, 2021, 5:23 PM IST
May 24, 2021, 3:55 PM IST
May 24, 2021, 3:25 PM IST
May 24, 2021, 1:48 PM IST
May 24, 2021, 12:55 PM IST
May 23, 2021, 5:58 PM IST
May 23, 2021, 4:08 PM IST
May 23, 2021, 2:40 PM IST
May 23, 2021, 12:09 PM IST
May 23, 2021, 11:47 AM IST
May 23, 2021, 10:51 AM IST
May 21, 2021, 6:26 PM IST
May 21, 2021, 4:53 PM IST
May 21, 2021, 3:55 PM IST
May 21, 2021, 2:37 PM IST
May 21, 2021, 12:41 PM IST
Transcending vote bank politics: Sreedharan helps families get power connection as per poll promises
May 20, 2021, 5:15 PM IST